Log In
BCIQ
Print this Print this
 

DC Vaccine containing WT1/PRAME

  Manage Alerts
Collapse Summary General Information
Company Medigene AG
DescriptionAutologous IL-12p70 producing monocyte derived dendritic cell (DC) vaccine
Molecular Target Wilms tumor 1 (WT1) ; Preferentially expressed antigen in melanoma (PRAME)
Mechanism of ActionVaccine
Therapeutic ModalityActive immunotherapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today